Brighton Jones’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Brighton Jones's RPRX Position: Q3 2026 in Review
Brighton Jones increased its Royalty Pharma (RPRX) stake by 1.7% in Q3 2026, buying an estimated $7.37K and bringing the position to 7,578 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #861.
Brighton Jones first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 585 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Brighton Jones held 7,578 shares of Royalty Pharma worth $442K as of Q3 2026.
- Brighton Jones bought 125 Royalty Pharma shares in Q3 2026, an estimated $7.37K.
- Royalty Pharma made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #861 holding.
- Brighton Jones first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
- 585 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.